Maturitas
Volume 55, Issue 3 , Pages 278-287 , 20 October 2006

Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation

  • A.L. Eilertsen

      Affiliations

    • Department of Hematology, Ullevaal University Hospital Trust, Hematological Research Laboratory, NO-0407 Oslo, Norway
    • Corresponding Author InformationCorresponding author. Tel.: +47 22119240; fax: +47 22119942.
    • ,
  • E. Qvigstad

      Affiliations

    • Department of Gynecology, Ullevaal University Hospital Trust, Oslo, Norway
    • ,
  • T.O. Andersen

      Affiliations

    • Department of Hematology, Ullevaal University Hospital Trust, Hematological Research Laboratory, NO-0407 Oslo, Norway
    • ,
  • L. Sandvik

      Affiliations

    • Center of Clinical Research, Ullevaal University Hospital Trust, Oslo, Norway
    • ,
  • P.M. Sandset

      Affiliations

    • Department of Hematology, Ullevaal University Hospital Trust, Hematological Research Laboratory, NO-0407 Oslo, Norway

Received 30 January 2006 ,Revised 4 April 2006 ,Accepted 11 April 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0378-5122(06)00132-0

doi: 10.1016/j.maturitas.2006.04.012

Maturitas
Volume 55, Issue 3 , Pages 278-287 , 20 October 2006

Article Tools

* Image Usage & Resolution